Published Date: 11 Sep 2024
The c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an acceptable safety profile in patients of Asian race with c-Met protein-overexpressing, epidermal growth factor receptor ...
Read Full News1.
Vaccine elicits strong immune response in patients with pancreatic and colorectal cancer
2.
According to a study, breast cancer in Syrian refugees tends to be diagnosed at an earlier stage and with more advanced tumors.
3.
Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice
4.
Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control
5.
A prostate cancer risk prediction algorithm could help target men at highest risk
1.
Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology
2.
Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment
3.
Understanding Pomalidomide: A promising drug for multiple myeloma treatment
4.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
5.
General Practitioners Role in Diagnosing Ovarian Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
5.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation